dmlt
Vaccineexperimental
Clinical trial activity
9 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
8
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01147445)
Timeline
Indications
Mechanism of action
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dmlt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06692907 | Phase 2 | Jan 13, 2025 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT05961059 | Phase 1 | Nov 30, 2023 | Centre for Infectious Disease Research in Zambia (CIDRZ), European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Leiden University, PATH, United States Army, University of Gothenburg |
| NCT04826094 | Phase 1 | Mar 16, 2021 | Kenya Medical Research Institute, National Institute of Allergy and Infectious Diseases (NIAID), The EMMES Corporation, United States Army |
| NCT04232943 | Phase 1 | Jan 28, 2020 | PATH |
| NCT03922061 | Phase 1 | Mar 19, 2019 | University of Vermont |
| NCT03404674 | Phase 1 | Jan 16, 2018 | PATH, United States Army, United States Navy |
| NCT02531802 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2015 | International Center for Diarrheal Disease Research, PATH, Scandinavian Biopharma AB |
| NCT01739231 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2012 | Johns Hopkins University, PATH |
| NCT01147445 | Phase 1 | Sep 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PATH | Academic/Hospital | 5 | 4 | 2 | 2012 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 2 | 2010 |
| United States Army | Government | 3 | 0 | 1 | 2018 |
| Centre for Infectious Disease Research in Zambia (CIDRZ) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| European Vaccine Initiative (EVI), Heidelberg, Germany | Government | 1 | 0 | 1 | 2023 |
| International Center for Diarrheal Disease Research | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Kenya Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Scandinavian Biopharma AB | For profit | 1 | 0 | 1 | 2015 |
| The EMMES Corporation | For profit | 1 | 0 | 1 | 2021 |
| United States Navy | Government | 1 | 0 | 1 | 2018 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Vermont | Academic/Hospital | 1 | 1 | 1 | 2019 |
15 organizations
Page 1 / 1